C12N 2710/10211
Aviadenovirus
Official title: Aviadenovirus, e.g. fowl adenovirus A
C12N2710/10211 (Aviadenovirus) appears on 43 US grants and 47 published applications in this corpus.
Search patents in C12N- Granted patents
- 43
- Published applications
- 47
- Assignees
- 47
- Inventors
- 140
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 6 | 0 |
| 2002 | 1 | 3 |
| 2003 | 1 | 1 |
| 2004 | 4 | 2 |
| 2005 | 1 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 3 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 3 | 2 |
| 2016 | 3 | 3 |
| 2017 | 0 | 2 |
| 2018 | 1 | 2 |
| 2019 | 2 | 2 |
| 2020 | 1 | 3 |
| 2021 | 0 | 1 |
| 2022 | 4 | 6 |
| 2023 | 0 | 1 |
| 2024 | 1 | 2 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
- C12N 2710/10241Use of virus, viral particle or viral elements as a vectorIndexing code18
- C12N 2710/10234Use of virus or viral component as vaccineIndexing code15
- C12N 2710/10222New viral proteins or individual genes, new structural or functional aspects ofIndexing code14
- C12N 2710/10251Methods of production or purification of viral materialIndexing code9
- C12N 2710/10221Viruses as suchIndexing code5
- C12N 2710/10261Methods of inactivation or attenuationIndexing code5
- C12N 2710/10271Demonstrated in vivo effectIndexing code4
- C12N 2710/10223Virus like particles [vlp]Indexing code0
All 12 subgroupsShow fewer
Recent patents
- tFIBER protein fragment of avian egg drop syndrome virus and vaccine composition prepared thereof, preparation method and use14 Oct 2025US 12,440,551 B2Pulike Biological Engineering, Inc.
- Codon-optimized human NPC1 genes for the treatment of Niemann-Pick type C1 deficiency and related conditions15 Oct 2024US 12,116,577 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods and compositions for performing continuous directed evolution16 Aug 2022US 11,414,677 B2Massachusetts Institute of Technology
- Avian influenza and fowl adenovirus type 4 bi-combined genetic engineering subunit vaccine and method for preparing the same19 Apr 2022US 11,305,006 B2Zhaoqing Dahuanong Biology Medicine Co., Ltd
- Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof29 Mar 2022US 11,285,206 B2Institute of Animal Husbandry and Veterinary Sciences, Hubei Academy of Agricultural Sciences
- Fusion proteins against sialosylated glycosphingolipids and sialated glycoproteins and uses thereof20 Nov 2025US 2025/0353901 A1On. Target Molecules Biotech Inc.
- Fowl adenovirus subunit vaccine and production method thereof20 Feb 2025US 2025/0057943 A1Veterinarmedizinische Universitat Wien
- Codon-optimized human npc1 genes for the treatment of niemann-pick type c1 deficiency and related conditions12 Dec 2024US 2024/0409948 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
- Veterinary viral vector29 Aug 2024US 2024/0285748 A1
- Replication-deficient avian adenoviral vectors, their design and uses11 May 2023US 2023/0140994 A1Greffex, Inc.
Most cited
By later US patents
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Avian adenoassociated virus and uses thereof41US 9,238,800 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016
- Composition for introducing nucleic acid complexes into higher eucaryotic cells34US 6,022,735 ABoehringer Ingelheim International GmbH · 2000
- Composition for introducing nucleic acid complexes into higher eucaryotic cells27US 6,274,322 B1Boehringer Ingelheim International GmbH · 2001
- Composition for introducing nucleic acid complexes into higher eucaryotic cells25US 6,077,663 ABoehringer Ingelheim International GmbH · 2000